Challenges to generic medicines utilization in Yemeni healthcare system
نویسندگان
چکیده
منابع مشابه
Healthcare Utilization Monitoring System in Korea
OBJECTIVES It is important to monitor the healthcare utilization of patients at the national level to make evidence-based policy decisions and manage the nation's healthcare sector. The Health Insurance Review & Assessment Service (HIRA) has run a Healthcare Utilization Monitoring System (HUMS) since 2008. The objective of this paper is to introduce HIRA's HUMS. METHODS This study described t...
متن کاملGeneric medicines are not substandard medicines.
1 who work for the industry-funded Hudson Institute, advocate the use of patented drugs, pointing to what they say are risks associated with generic drugs. They confuse generic drugs with old, substandard, ineffective, and counterfeit drugs. Generic does not mean old. The 1996 World Trade Organisation (WTO) Agreements mandate all member countries to provide 20-year patent protection for medicin...
متن کاملEquity in health: From concept to application in healthcare system
Equity is the prime virtue of social institutions, and its role is as truth is for human thought system [1]. Equity has been studied in various areas such as economics, politics, and judicial system. One of the areas of social equity that has recently been considered by experts is health. Health is defined as complete physical, mental, and social well-being. Health refers not only to the physi...
متن کاملSecurity Challenges in Fog Computing in Healthcare
Background and Aim: The Fog Computing is a highly virtualized platform that provides storage, computing and networking services between the Cloud data centers and end devices. Fog computing fits the characteristics of real-time health monitoring systems. In such systems, a large amount of data is acquired from a multitude of bio and environmental sensors. On the other hand, its distribution and...
متن کاملClinical Studies – Generic Medicines
Clinical testing is not the only way to discover drug effects on people. That is the reason controlled clinical trials are the only legal basis for central regulatory agencies in each country, such as FDA, to conclude that a new drug has clinical effectiveness for a drug or biologic. Before clinical testing begins, researchers analyze the drug’s main physical and chemical properties in the labo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Generics and Biosimilars Initiative Journal
سال: 2013
ISSN: 2033-6403,2033-6772
DOI: 10.5639/gabij.2013.0202.017